Apterna Limited

APTERNA

In the heading, Int. Cl. 1 is deleted and in the statement, line 6 is deleted; and in line 7 nucleic acid aptamers for medical and veterinary purposes is deleted.;[ Nucleic acid sequences for medical and veterinary purposes; nucleic acid aptamers for medical and veterinary purposes; ] pharmaceutical preparations for the treatment of pancreatic cancer, gastrointestinal tumors, glioblastoma, and cancer; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of pancreatic cancer, gastrointestinal tumors, glioblastoma, and cancer;[ Nucleic acid for laboratory use; nucleic acid aptamers for laboratory use ];Licensing of drugs and medicine; consultancy and information services relating to licensing of drugs and medicine;The wording APTERNA has no meaning in a foreign language.;Medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, testing, design and development services, namely, research and development of drugs and medicine; medical research; laboratory research in the field of medicine and pharmaceuticals; scientific research; product development, namely, development of prognostic and diagnostic tools; consultation in the fields of drug and medicine research, laboratory and scientific research, and product development;

APTERNA

Licensing of drugs and medicine; consultancy and information services relating to licensing of drugs and medicine;Medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, testing, design and development services, namely, research and development of drugs and medicine; medical research; laboratory research in the field of medicine and pharmaceuticals; scientific research; product development, namely, development of prognostic and diagnostic tools; consultation in the fields of drug and medicine research, laboratory and scientific research, and product development;